Search
for
Sort by
Research 661–690 of 1000+
- Acetyl-CoA synthesis in the skin is a key determinant of systemic lipid homeostasis
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- A review of Janus kinase inhibitor use in scarring alopecia
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Inhibition of 5α-Reductase, IL-6 Secretion, and Oxidation Process of Equisetum debile Roxb. ex Vaucher Extract as Functional Food and Nutraceuticals Ingredients
- Mechanism of Salutary Effects of Finasteride on Post-traumatic Immune/Inflammatory Response
- Brief Treatment Modalities of Alopecia Areata: Review Article
- Modulating immune responses in alopecia: therapeutic insights and potential targets of antisense oligonucleotides
- Androgenetic alopecia; drug safety and therapeutic strategies
- Telogen Effluvium: Is There a Need for a New Classification
- Geranylated Coumarins From Thai Medicinal Plant Mammea siamensis With Testosterone 5α-Reductase Inhibitory Activity
- Pathomechanism of androgenetic alopecia and new treatment
- Novel drugs of United States Food and Drug Administration approved in 2024
- Th1 effector CD4 T cells rely on IFN-γ production to induce alopecia areata
- Quality of life assessment in patients with androgenetic alopecia
- Cicatricial Alopecia Research Foundation meeting, May 2016: Progress towards the diagnosis, treatment and cure of primary cicatricial alopecias
- Ritlecitinib: First Approval
- The non-neuronal and nonmuscular effects of botulinum toxin: an opportunity for a deadly molecule to treat disease in the skin and beyond
- Protein kinase C is a key target for attenuation of Leigh syndrome by rapamycin
- An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
- Advances in the mechanism and new therapies of alopecia areata
- Treatment of Androgenetic Alopecia Using PRP to Target Dysregulated Mechanisms and Pathways
- Finasteride inhibited brain dopaminergic system and open-field behaviors in adolescent male rats
- T <sub>H</sub> 1 effector CD4 T cells rely on IFN-γ production to induce alopecia areata
- Selective Expression of Chemokine Monokine Induced by Interferon-γ in Alopecia Areata
- Androgenetic alopecia: a review
- Exosomal microRNA-Based therapies for skin diseases
- Cyclooxygenase-2 overexpression in the skin of transgenic mice results in suppression of tumor development.
- Male sex hormones, aging, and inflammation
- Role of janus kinase inhibitors in the treatment of alopecia areata